Motor Neuron Susceptibility in ALS/FTD

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the death of both upper and lower motor neurons (MNs) in the brain, brainstem and spinal cord. The neurodegenerative mechanisms leading to MN loss in ALS are not fully understood. Importantly, the reasons why MNs are...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neuroscience Vol. 13; p. 532
Main Authors Ragagnin, Audrey M G, Shadfar, Sina, Vidal, Marta, Jamali, Md Shafi, Atkin, Julie D
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 27.06.2019
Frontiers Media S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the death of both upper and lower motor neurons (MNs) in the brain, brainstem and spinal cord. The neurodegenerative mechanisms leading to MN loss in ALS are not fully understood. Importantly, the reasons why MNs are specifically targeted in this disorder are unclear, when the proteins associated genetically or pathologically with ALS are expressed ubiquitously. Furthermore, MNs themselves are not affected equally; specific MNs subpopulations are more susceptible than others in both animal models and human patients. Corticospinal MNs and lower somatic MNs, which innervate voluntary muscles, degenerate more readily than specific subgroups of lower MNs, which remain resistant to degeneration, reflecting the clinical manifestations of ALS. In this review, we discuss the possible factors intrinsic to MNs that render them uniquely susceptible to neurodegeneration in ALS. We also speculate why some MN subpopulations are more vulnerable than others, focusing on both their molecular and physiological properties. Finally, we review the anatomical network and neuronal microenvironment as determinants of MN subtype vulnerability and hence the progression of ALS.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Reviewed by: Mamede De Carvalho, Universidade de Lisboa, Portugal; Adrian Israelson, Ben-Gurion University of the Negev, Israel
Edited by: Alberto Lleo, Hospital de la Santa Creu i Sant Pau, Spain
This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience
ISSN:1662-4548
1662-453X
1662-453X
DOI:10.3389/fnins.2019.00532